Transabdominal lidocaine to induce fetal demise: a cohort study.

Reeves, Matthew F; Goldfarb, Caroline N; Rubin, Stacey Leigh; Kuperstock, Jessica L; DiBianco, Leah; Picciotto, Andrea

Reeves, Matthew F; Goldfarb, Caroline N; Rubin, Stacey Leigh; Kuperstock, Jessica L; DiBianco, Leah; Picciotto, Andrea.

Affiliation

Reeves MF; DuPont Clinic, Washington, District of Columbia, USA mreeves5@jhu.edu.
Goldfarb CN; The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.
Rubin SL; Department of Population, Family, and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Balitmore, Maryland, USA.
Kuperstock JL; Department of Obstetrics & Gynecology, Stanford University School of Medicine, Stanford, California, USA.
DiBianco L; DuPont Clinic, Washington, District of Columbia, USA.
Picciotto A; Harvard Medical School, Boston, Massachusetts, USA.

BMJ Sex Reprod Health ; 48(4): 275-280, 2022 10.

Article de En | MEDLINE | ID: mdl-35383110

Sujet(s)
Mots clés

Abortifacient Agents; abortion, induced; family planning services

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Arrêt cardiaque / Lidocaïne Type d'étude: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limites: Female / Humans / Newborn / Pregnancy Langue: En Journal: BMJ Sex Reprod Health Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google